NCT05448339View on ClinicalTrials.gov

Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

197

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 31, 2023

Study Completion Date

January 1, 2024

Conditions
Liver Transplantation
Interventions
COMBINATION_PRODUCT

PVHA or TACE

PVHA or TACE

Trial Locations (1)

200000

Shanghai General Hospital, Shanghai

All Listed Sponsors
lead

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

NCT05448339 - Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation | Biotech Hunter | Biotech Hunter